Bridging mechanism and clinic: unlocking the full potential of oncolytic virus-based immunotherapy. [PDF]
Hua X +6 more
europepmc +1 more source
Clinical dose of enoxaparin enhances oncolytic virus M1 infection and antitumor efficacy in human bladder cancer. [PDF]
Xiao X +14 more
europepmc +1 more source
Enhancing the therapeutic potential of oncolytic virotherapy for melanoma treatment
reservedMelanoma remains a globally relevant malignancy. Although various treatments have been developed over time, few are effective against rarer mutations.
PAROLIN, BEATRICE
core
Development and Validation of a Rapid Titer Assay for the Oncolytic Virus oHSV2 Expressing a PD-L1/CD3 Bispecific Antibody. [PDF]
Zhang S +6 more
europepmc +1 more source
Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis. [PDF]
Zhang Z +11 more
europepmc +1 more source
Phase I Study of Oncolytic Virus VV1 as Monotherapy or in Combination with Avelumab in Patients with Relapsed Refractory Solid Tumors. [PDF]
Merchan JR +12 more
europepmc +1 more source
Oncolytic virus therapy for osteosarcoma: mechanisms, opportunities, and challenges. [PDF]
Wang JW, Ge X, Liu JH, Zhang X.
europepmc +1 more source
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells. [PDF]
Tang N +11 more
europepmc +1 more source
Oncolytic virus and immunogenic cell death in cancer therapy. [PDF]
Cao G, Ding C, Dai J, Qiu X.
europepmc +1 more source

